請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/66594
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 程蘊菁 | |
dc.contributor.author | Yue-Yuan Lee | en |
dc.contributor.author | 李悅源 | zh_TW |
dc.date.accessioned | 2021-06-17T00:45:14Z | - |
dc.date.available | 2017-03-02 | |
dc.date.copyright | 2012-03-02 | |
dc.date.issued | 2011 | |
dc.date.submitted | 2012-01-06 | |
dc.identifier.citation | 1. Dawson-Hughes B, Looker A, Tosteson A, Johansson H, Kanis J, Melton L. The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008. Osteoporosis International:1-10.
2. Yang N-P, Deng C-Y, Chou Y-J, Chen P-Q, Lin C-H, Chou P, et al. Estimated prevalence of osteoporosis from a Nationwide Health Insurance database in Taiwan. Health Policy. 2006;75(3):329-37. 3. Wang Y, Tao Y, Hyman M, Li J, Chen Y. Osteoporosis in China. Osteoporosis International. 2009;20(10):1651-62. 4. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312(7041):1254 - 9. 5. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. The Lancet. 2002;359(9321):1929-36. 6. Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, et al. Mortality after osteoporotic fractures. Osteoporosis International. 2004;15(1):38-42. 7. Haleem S, Lutchman L, Mayahi R, Grice JE, Parker MJ. Mortality following hip fracture: Trends and geographical variations over the last 40 years. Injury. 2008;39(10):1157-63. 8. LAU, C. EM. Osteoporosis: A worldwide problem and the implications in Asia. Singapore, SINGAPOUR: Academy of Medicine; 2002. 9. Expert Panel on Detection E, Adults ToHBCi. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA: The Journal of the American Medical Association. 2001;285(19):2486-97. 10. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine. 2006;23(5):469-80. 11. Ford ES, Giles WH, Dietz WH. Prevalence of the Metabolic Syndrome Among US Adults. JAMA: The Journal of the American Medical Association. 2002;287(3):356-9. 12. Deaprtment of Health, Executive Yuan (2007) 2002 to 2007 Prevalence survey of Triple-High status, Republic of China. http://www.bhp.doh.gov.tw. 13. Villareal DT, Apovian CM, Kushner RF, Klein S. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. The American Journal of Clinical Nutrition. 2005;82(5):923-34. 14. McTigue KM, Hess R, Ziouras J. Obesity in Older Adults: A Systematic Review of the Evidence for Diagnosis and Treatment[ast]. Obesity. 2006;14(9):1485-97. 15. Laet C, Kanis J, Oden A, Johanson H, Johnell O, Delmas P, et al. Body mass index as a predictor of fracture risk: A meta-analysis. Osteoporosis International. 2005;16(11):1330-8. 16. Reid IR, Plank LD, Evans MC. Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. Journal of Clinical Endocrinology & Metabolism. 1992;75(3):779-82. 17. Fu X, Ma X, Lu H, He W, Wang Z, Zhu S. Associations of fat mass and fat distribution with bone mineral density in pre- and postmenopausal Chinese women. Osteoporosis International. 2011;22(1):113-9. 18. Bhupathiraju SN, Dawson-Hughes B, Hannan MT, Lichtenstein AH, Tucker KL. Centrally located body fat is associated with lower bone mineral density in older Puerto Rican adults. The American Journal of Clinical Nutrition. 2011;94(4):1063-70. 19. Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD. Reciprocal Relations of Subcutaneous and Visceral Fat to Bone Structure and Strength. Journal of Clinical Endocrinology & Metabolism. 2009;94(9):3387-93. 20. Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bone-mineral loss in elderly white women: a prospective study. The Lancet. 1999;354(9183):971-5. 21. Gotoh M, Mizuno K, Ono Y, Takahashi M. High Blood Pressure, Bone-Mineral Loss and Insulin Resistance in Women. Hypertens Res. 2005;28(7):565-70. 22. Yamaguchi T, Kanazawa I, Yamamoto M, Kurioka S, Yamauchi M, Yano S, et al. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone. 2009;45(2):174-9. 23. Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic Review of Type 1 and Type 2 Diabetes Mellitus and Risk of Fracture. American Journal of Epidemiology. 2007;166(5):495-505. 24. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporosis International. 2007;18(4):427-44. 25. Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, et al. Risk of Fracture in Women with Type 2 Diabetes: the Women’s Health Initiative Observational Study. Journal of Clinical Endocrinology & Metabolism. 2006;91(9):3404-10. 26. Dennison EM, Syddall HE, Aihie Sayer A, Martin HJ, Cooper C. Lipid profile, obesity and bone mineral density: the Hertfordshire Cohort Study. Qjm. 2007;100(5):297-303. 27. Hsu Y-H, Venners SA, Terwedow HA, Feng Y, Niu T, Li Z, et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. The American Journal of Clinical Nutrition. 2006;83(1):146-54. 28. Lee KS, Cho JH, Park CH, Kim BS, Cho KH, Lee SH, et al. Relationship between Plasma Lipids and Osteoporosis in Korean Postmenopausal Women. J Korean Geriatr Soc. 2011;15(2):99-106. 29. Kinjo M, Setoguchi S, Solomon DH. Bone Mineral Density in Adults with the Metabolic Syndrome: Analysis in a Population-Based U.S. Sample. J Clin Endocrinol Metab. 2007;92(11):4161-4. 30. Hernandez JL, Olmos JM, Pariente E, Martinez J, Valero C, Garcia-Velasco P, et al. Metabolic syndrome and bone metabolism: the Camargo Cohort Study. Menopause. 2010;17(5):955. 31. Park KK, Kim SJ, Moon ES. Association between bone mineral density and metabolic syndrome in postmenopausal Korean women. Gynecol Obstet Invest. 2010;69:145-52. 32. Kim HY, Choe JW, Kim HK, Bae SJ, Kim BJ, Lee SH, et al. Negative Association between Metabolic Syndrome and Bone Mineral Density in Koreans, Especially in Men. Calcified tissue international. 2010;86(5):350-8. 33. von Muhlen D, Safii S, Jassal S, Svartberg J, Barrett-Connor E. Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporosis International. 2007;18(10):1337-44. 34. Nelson HD, Helfand M, Woolf SH, Allan JD. Screening for Postmenopausal Osteoporosis: A Review of the Evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2002;137(6):529-41. 35. Kim HM, Park J, Ryu SY, Kim J. The Effect of Menopause on the Metabolic Syndrome Among Korean Women. Diabetes Care. 2007;30(3):701-6. 36. Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the Metabolic Syndrome: The Study of Women's Health Across the Nation. Arch Intern Med. 2008;168(14):1568-75. 37. Finkelstein JS, Brockwell SE, Mehta V, Greendale GA, Sowers MR, Ettinger B, et al. Bone Mineral Density Changes during the Menopause Transition in a Multiethnic Cohort of Women. Journal of Clinical Endocrinology & Metabolism. 2008;93(3):861-8. 38. Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK. International Variations in Hip Fracture Probabilities: Implications for Risk Assessment. Journal of Bone and Mineral Research. 2002;17(7):1237-44. 39. Lunt M, Felsenberg D, Reeve J, Benevolenskaya L, Cannata J, Dequeker J, et al. Bone Density Variation and Its Effects on Risk of Vertebral Deformity in Men and Women Studied in Thirteen European Centers: The EVOS Study. Journal of Bone and Mineral Research. 1997;12(11):1883-94. 40. Hanley D, Brown J, Tenenhouse A, Olszynski W, Ioannidis G, Berger C, et al. Associations Among Disease Conditions, Bone Mineral Density, and Prevalent Vertebral Deformities in Men and Women 50 Years of Age and Older: Cross Sectional Results From the Canadian Multicentre Osteoporosis Study. Journal of Bone and Mineral Research. 2003;18(4):784-90. 41. Tsuda K, Nishio I, Masuyama Y. Bone mineral density in women with essential hypertension. American journal of hypertension. 2001;14(7):704-7. 42. Mussolino ME, Gillum RF. Bone Mineral Density and Hypertension Prevalence in Postmenopausal Women: Results From the Third National Health and Nutrition Examination Survey. Annals of Epidemiology. 2006;16(5):395-9. 43. Adami S, Braga V, Zamboni M, Gatti D, Rossini M, Bakri J, et al. Relationship Between Lipids and Bone Mass in 2 Cohorts of Healthy Women and Men. Calcified tissue international. 2004;74(2):136-42. 44. Laet C, Kanis J, Oden A, Johanson H, Johnell O, Delmas P, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporosis International. 2005;16(11):1330-8. 45. Morin S, Tsang J, Leslie W. Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years. Osteoporosis International. 2009;20(3):363-70. 46. Janicka A, Wren TAL, Sanchez MM, Dorey F, Kim PS, Mittelman SD, et al. Fat Mass Is Not Beneficial to Bone in Adolescents and Young Adults. Journal of Clinical Endocrinology & Metabolism. 2007;92(1):143-7. 47. Felson DT, Zhang Y, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women: The framingham study. Journal of Bone and Mineral Research. 1993;8(5):567-73. 48. Reid IR, Ames R, Evans MC, Sharpe S, Gamble G, France JT, et al. Determinants of total body and regional bone mineral density in normal postmenopausal women--a key role for fat mass. Journal of Clinical Endocrinology & Metabolism. 1992;75(1):45-51. 49. Zhao L-J, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, et al. Correlation of Obesity and Osteoporosis: Effect of Fat Mass on the Determination of Osteoporosis. Journal of Bone and Mineral Research. 2008;23(1):17-29. 50. Thrailkill KM, Lumpkin CK, Bunn RC, Kemp SF, Fowlkes JL. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. American Journal of Physiology - Endocrinology And Metabolism. 2005;289(5):E735-E45. 51. Wittrant Y, Gorin Y, Woodruff K, Horn D, Abboud HE, Mohan S, et al. High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone. 2008;42(6):1122-30. 52. Melton LJ, Khosla S, Atkinson EJ, O'Fallon WM, Riggs BL. Relationship of Bone Turnover to Bone Density and Fractures. Journal of Bone and Mineral Research. 1997;12(7):1083-91. 53. Bergmann P, Body JJ, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, et al. Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club. International Journal of Clinical Practice. 2009;63(1):19-26. 54. Jassal SK, von Muhlen D, Barrett-Connor E. Measures of Renal Function, BMD, Bone Loss, and Osteoporotic Fracture in Older Adults: The Rancho Bernardo Study. Journal of Bone and Mineral Research. 2007;22(2):203-10. 55. Hsu C-Y, Cummings SR, McCulloch CE, Chertow GM. Bone mineral density is not diminished by mild to moderate chronic renal insufficiency. Kidney Int. 2002;61(5):1814-20. 56. Holick MF. Vitamin D Deficiency. New England Journal of Medicine. 2007;357(3):266-81. 57. Baumeister H, Kriston L, Bengel J, Harter M. High agreement of self-report and physician-diagnosed somatic conditions yields limited bias in examining mental–physical comorbidity. Journal of Clinical Epidemiology. 2010;63(5):558-65. 58. Goldman N, Lin IF, Weinstein M, Lin Y-H. Evaluating the quality of self-reports of hypertension and diabetes. Journal of Clinical Epidemiology. 2003;56(2):148-54. 59. Blake GM, Fogelman I. The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgraduate Medical Journal. 2007;83(982):509-17. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/66594 | - |
dc.description.abstract | 背景:骨質疏鬆症造成骨折的風險增加與骨折後之高致死率是重要的健康議題。近期的研究發現代謝症侯群與低骨質密度的風險具有相關,但各研究的發現並不一致,也不曾有研究探討停經的狀態是否會影響兩者之間的相關。
方法:自2009到2010年間,我們以橫斷式研究,招募共1,577位年齡40至55歲之間,在台北美兆健康檢查中心參加健康檢查的台灣女性。使用雙能量放射線儀測量之腰椎骨質密度,來分析代謝症侯群與低骨質密度風險的相關。另進行分層分析,來探討代謝症侯群及個別組成因子與停經或其他干擾因子的交互作用對低骨質密度風險之影響。 結果:研究結果顯示代謝症侯群會降低女性低骨質密度的風險[adjusted OR (AOR) = 0.32, 95% confidence interval (CI) = 0.19-0.56]。腹部肥胖(AOR = 0.54, 95% CI = 0.35-0.84)、高血壓(AOR = 0.63, 95% CI = 0.43-0.94)、高空腹血糖(AOR = 0.66, 95% CI = 0.48-0.90)也會降低女性低骨質密度的風險。停經對代謝症侯群之個別因子無顯著交互作用存在(P interaction > 0.05 )。 結論:代謝症侯群、腹部肥胖、高血壓及高空腹血糖會降低女性低骨質密度的風險。停經與代謝症侯群之個別因子間無顯著交互作用。 | zh_TW |
dc.description.abstract | Background
Osteoporosis (OP) is a major public health issue because of it has been linked to increased fracture risk and the subsequent mortality. Metabolic syndrome (MetS) has been related to several health issues. However, the association between MetS and BMD has been inconsistent and no previous study has explored how menopausal status modified this association. Methods A total of 1,577 Taiwanese women aged 40 to 55 years old were recruited from the MJ Health Screening Center between 2009 and 2010. Bone mineral density (BMD, g/cm2) was measured at the lumbar spine by using dual-energy X-ray absorptiometry (DXA) and were tertiled (T1, T2, and T3). MetS is based on the definition from ATP III report with modification for the Asian criteria for waist circumference and fasting glucose. High BMD was defined as T2 plus T3, low BMD was defined as T1. This study was aimed to explore the association between MetS or individual component of MetS and BMD in Taiwanese women. We also explored how menopausal status or other potential confounders modified this association. Results Women with MetS had a decreased risk of low BMD [adjusted OR (AOR) = 0.32, 95% confidence interval (CI) = 0.19-0.56]. Women with abdominal obesity (AOR = 0.54, 95% CI = 0.35-0.84), high blood pressure (BP, AOR = 0.63, 95% CI = 0.43-0.94), or high fasting glucose (AOR = 0.66, 95% CI = 0.48-0.90) had a decreased risk of low BMD. Menopausal status did not significantly modify the association of each individual components of MetS (P interaction >0.05), or MetS itself, with BMD. Conclusions Women with MetS, abdominal obesity, high BP, or fasting glucose were significantly associated with a decreased risk of low BMD. Menopausal status did not significantly modify the associations between MetS or individual components of MetS and the risk of low BMD. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T00:45:14Z (GMT). No. of bitstreams: 1 ntu-100-R98846008-1.pdf: 654701 bytes, checksum: 871d23a16bd484c7e15f53c841149844 (MD5) Previous issue date: 2011 | en |
dc.description.tableofcontents | 口試委員會審定書 I
誌謝 II 摘要 III ABSTRACT IV 圖目錄 VII 表目錄 VIII CHAPTER 1. INTRODUCTION 1 1.1 IMPORTANCE OF BONE MINERAL DENSITY 1 1.2 METABOLIC SYNDROME 2 1.3 EPIDEMIOLOGIC STUDIES RELATING METABOLIC SYNDROME AND BONE MINERAL DENSITY 2 1.4 AIMS 3 CHAPTER 2. MATERIALS AND METHODS 4 2.1 STUDY POPULATION 4 2.2 BONE MINERAL DENSITY MEASUREMENT 5 2.3 METABOLIC SYNDROME 5 2.4 STATISTICAL ANALYSES 5 CHAPTER 3. RESULTS 7 3.1 CHARACTERISTICS OF THE STUDY POPULATION 7 3.2 METABOLIC SYNDROME AND BONE MINERAL DENSITY 7 3.3 EFFECT MODIFICATION BY BODY WEIGHT 8 3.4 EFFECT MODIFICATION BY MENOPAUSAL STATUS 9 3.5 EFFECT MODIFICATION BY SERUM ALKALINE PHOSPHATASE LEVEL 10 3.6 EFFECT MODIFICATION BY SERUM CREATININE LEVEL 11 CHAPTER 4. DISCUSSION 12 4.1 MAIN FINDINGS AND COMPARISONS WITH PREVIOUS STUDIES 12 4.2 POSTULATED MECHANISM 14 4.3 STRENGTHS AND LIMITATIONS 15 4.4 CONCLUSION 16 REFERENCES 17 | |
dc.language.iso | en | |
dc.title | 臺灣女性代謝症候群與骨質密度之關聯研究 | zh_TW |
dc.title | Association between Metabolic Syndrome and Bone Mineral Density in Taiwanese Women | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 李文宗,丘政民,蔡克嵩 | |
dc.subject.keyword | 代謝症侯群,骨質密度,骨質疏鬆症,停經,女性, | zh_TW |
dc.subject.keyword | Metabolic syndrome,bone mineral density,osteoporosis,menopause,women, | en |
dc.relation.page | 49 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2012-01-09 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-100-1.pdf 目前未授權公開取用 | 639.36 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。